Myriam Anne Armant, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scleral Diseases | 1 | 2022 | 22 | 0.840 |
Why?
|
Limbus Corneae | 2 | 2022 | 142 | 0.820 |
Why?
|
Epithelium, Corneal | 2 | 2022 | 241 | 0.780 |
Why?
|
Corneal Diseases | 1 | 2022 | 615 | 0.510 |
Why?
|
Interleukin-12 | 6 | 1999 | 579 | 0.370 |
Why?
|
Anemia, Sickle Cell | 3 | 2023 | 1017 | 0.330 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2019 | 227 | 0.310 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 2 | 2018 | 23 | 0.290 |
Why?
|
Lentivirus | 2 | 2020 | 501 | 0.270 |
Why?
|
Receptors, IgE | 3 | 1999 | 389 | 0.260 |
Why?
|
Cell Transplantation | 2 | 2022 | 477 | 0.250 |
Why?
|
Interferon-gamma | 5 | 1999 | 3199 | 0.240 |
Why?
|
Transplantation, Autologous | 4 | 2022 | 2123 | 0.220 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2023 | 131 | 0.220 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 122 | 0.220 |
Why?
|
Amniotic Fluid | 3 | 2011 | 366 | 0.210 |
Why?
|
Hydroxyurea | 1 | 2023 | 290 | 0.210 |
Why?
|
Fetal Hemoglobin | 2 | 2023 | 341 | 0.210 |
Why?
|
Eczema | 1 | 2023 | 229 | 0.190 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2019 | 272 | 0.190 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2022 | 358 | 0.190 |
Why?
|
T-Lymphocytes | 7 | 2018 | 10163 | 0.190 |
Why?
|
Genetic Vectors | 4 | 2020 | 3420 | 0.190 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 113 | 0.180 |
Why?
|
gamma-Globins | 1 | 2020 | 95 | 0.180 |
Why?
|
Fanconi Anemia | 1 | 2022 | 319 | 0.180 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 314 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 6 | 2023 | 3381 | 0.170 |
Why?
|
Membrane Glycoproteins | 3 | 2002 | 3769 | 0.170 |
Why?
|
Multigene Family | 1 | 2002 | 1102 | 0.170 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2020 | 174 | 0.170 |
Why?
|
Interleukin-2 | 2 | 1996 | 1887 | 0.160 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
Chromosomes, Human, X | 1 | 2020 | 296 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 4 | 2017 | 1625 | 0.160 |
Why?
|
Blood Component Removal | 1 | 2018 | 125 | 0.150 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 249 | 0.150 |
Why?
|
Graft Survival | 3 | 2019 | 3733 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
Monokines | 2 | 1999 | 75 | 0.150 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2017 | 559 | 0.140 |
Why?
|
Cells, Cultured | 10 | 2022 | 19223 | 0.140 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 495 | 0.140 |
Why?
|
Down-Regulation | 3 | 2020 | 3001 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 609 | 0.140 |
Why?
|
Adrenoleukodystrophy | 1 | 2017 | 123 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 314 | 0.130 |
Why?
|
Neutropenia | 1 | 2021 | 891 | 0.130 |
Why?
|
Rabbits | 1 | 2022 | 4886 | 0.130 |
Why?
|
Monocytes | 4 | 1999 | 2593 | 0.130 |
Why?
|
Metformin | 1 | 2022 | 829 | 0.130 |
Why?
|
Gammaretrovirus | 1 | 2014 | 54 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 2 | 1999 | 1835 | 0.130 |
Why?
|
Interleukin-7 | 1 | 1995 | 142 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1225 | 0.120 |
Why?
|
Antigens, CD | 3 | 1999 | 4024 | 0.120 |
Why?
|
Rare Diseases | 1 | 2019 | 554 | 0.120 |
Why?
|
Tissue Engineering | 3 | 2011 | 1877 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.120 |
Why?
|
Antigens, CD34 | 4 | 2020 | 657 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 789 | 0.120 |
Why?
|
16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 1998 | 2524 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2023 | 3678 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2022 | 1618 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1699 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5425 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2867 | 0.110 |
Why?
|
Carrier Proteins | 3 | 1999 | 5019 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2890 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1670 | 0.100 |
Why?
|
Apoptosis | 5 | 2014 | 9715 | 0.100 |
Why?
|
Flow Cytometry | 5 | 2014 | 5975 | 0.090 |
Why?
|
Regenerative Medicine | 1 | 2013 | 306 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 665 | 0.090 |
Why?
|
Galectin 1 | 1 | 2011 | 131 | 0.090 |
Why?
|
Mouth Mucosa | 1 | 2012 | 434 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 176 | 0.090 |
Why?
|
Research Support as Topic | 1 | 2014 | 704 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3020 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 1995 | 1606 | 0.090 |
Why?
|
Cell Transformation, Viral | 1 | 2011 | 565 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2513 | 0.080 |
Why?
|
Diaphragm | 1 | 2011 | 347 | 0.080 |
Why?
|
Fetal Blood | 2 | 2013 | 1317 | 0.080 |
Why?
|
Dinoprostone | 1 | 2011 | 600 | 0.080 |
Why?
|
Humans | 42 | 2023 | 742088 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1314 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2011 | 525 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 3504 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2941 | 0.070 |
Why?
|
Tendons | 1 | 2011 | 548 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2011 | 1820 | 0.070 |
Why?
|
Bioprosthesis | 1 | 2011 | 596 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 1995 | 2133 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1915 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1040 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2011 | 495 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2010 | 2723 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.060 |
Why?
|
Animals | 14 | 2022 | 168561 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 1995 | 5519 | 0.060 |
Why?
|
Cryopreservation | 3 | 2017 | 664 | 0.060 |
Why?
|
Models, Animal | 1 | 2011 | 2170 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2018 | 804 | 0.060 |
Why?
|
Transcription Factors | 2 | 2023 | 12164 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9410 | 0.060 |
Why?
|
Mice | 7 | 2022 | 81045 | 0.060 |
Why?
|
Cytokines | 4 | 2021 | 7317 | 0.060 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2023 | 160 | 0.060 |
Why?
|
HIV | 1 | 2010 | 1600 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1994 | 4414 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2506 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 1995 | 4553 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 1434 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1866 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 115 | 0.050 |
Why?
|
Fibroblasts | 1 | 2012 | 4143 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1820 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 2012 | 354 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2022 | 279 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2023 | 2066 | 0.050 |
Why?
|
Gene Silencing | 2 | 2020 | 1538 | 0.050 |
Why?
|
Mitochondria | 1 | 2014 | 3520 | 0.050 |
Why?
|
Clone Cells | 1 | 2023 | 1692 | 0.050 |
Why?
|
Chromones | 1 | 1999 | 154 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6756 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1999 | 52 | 0.040 |
Why?
|
Thrombospondins | 1 | 1999 | 197 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2019 | 161 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2020 | 378 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2002 | 592 | 0.040 |
Why?
|
Immune Tolerance | 2 | 1998 | 2257 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7901 | 0.040 |
Why?
|
CD40 Ligand | 2 | 1998 | 526 | 0.040 |
Why?
|
Complementarity Determining Regions | 1 | 2018 | 149 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 591 | 0.040 |
Why?
|
Child | 6 | 2022 | 77478 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23387 | 0.040 |
Why?
|
Androstadienes | 1 | 1999 | 346 | 0.040 |
Why?
|
Interleukin-15 | 1 | 1998 | 184 | 0.040 |
Why?
|
Amniocentesis | 2 | 2008 | 116 | 0.040 |
Why?
|
Benzylamines | 1 | 2018 | 226 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1999 | 482 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2023 | 5062 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2211 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1328 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 1995 | 12071 | 0.040 |
Why?
|
Pilot Projects | 2 | 2020 | 8297 | 0.040 |
Why?
|
Morpholines | 1 | 1999 | 561 | 0.040 |
Why?
|
Caspases | 1 | 1999 | 928 | 0.030 |
Why?
|
Cell Division | 2 | 2018 | 4564 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2797 | 0.030 |
Why?
|
Interphase | 1 | 1996 | 224 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1879 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
Enterotoxins | 1 | 1997 | 368 | 0.030 |
Why?
|
United States Food and Drug Administration | 2 | 2014 | 1581 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 88 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 647 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1875 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21596 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1176 | 0.030 |
Why?
|
Forms and Records Control | 1 | 2014 | 160 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56350 | 0.030 |
Why?
|
Erythrocytes | 1 | 2023 | 2452 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1995 | 644 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2715 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 1997 | 969 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2012 | 1341 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1998 | 1000 | 0.030 |
Why?
|
Keratin-3 | 1 | 2012 | 3 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 40955 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1597 | 0.030 |
Why?
|
Ligands | 2 | 1998 | 3293 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2014 | 10472 | 0.030 |
Why?
|
Cell Separation | 2 | 2008 | 1749 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 29717 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1057 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 291 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 375 | 0.020 |
Why?
|
Cell Communication | 1 | 1998 | 1619 | 0.020 |
Why?
|
Amnion | 1 | 2012 | 208 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 85649 | 0.020 |
Why?
|
Dermis | 1 | 2012 | 207 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2014 | 2049 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1009 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1101 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9274 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2013 | 612 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1994 | 1262 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 13029 | 0.020 |
Why?
|
United States | 5 | 2020 | 69693 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 430 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2011 | 186 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2011 | 233 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2010 | 213 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1889 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1299 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 228 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 250 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 898 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2014 | 1099 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2011 | 317 | 0.020 |
Why?
|
Gestational Age | 2 | 2008 | 3490 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1997 | 1449 | 0.020 |
Why?
|
Adult | 6 | 2023 | 213712 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3800 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1999 | 1596 | 0.020 |
Why?
|
Primates | 1 | 2011 | 543 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5867 | 0.020 |
Why?
|
Phagocytosis | 1 | 2014 | 1538 | 0.020 |
Why?
|
Sheep | 1 | 2011 | 1437 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2222 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3711 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1806 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9387 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2851 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 670 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6974 | 0.020 |
Why?
|
Male | 6 | 2021 | 349538 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Serum | 1 | 2007 | 212 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4353 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2014 | 1255 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1998 | 4379 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2010 | 804 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 62966 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8621 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
Culture Media | 1 | 2007 | 902 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3339 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4771 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1994 | 3199 | 0.020 |
Why?
|
Electroencephalography | 1 | 2019 | 6142 | 0.020 |
Why?
|
Female | 7 | 2021 | 379592 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15994 | 0.010 |
Why?
|
Specimen Handling | 1 | 2008 | 692 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2382 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2479 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3062 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4211 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1402 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7790 | 0.010 |
Why?
|
Cattle | 1 | 2007 | 3923 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3691 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7716 | 0.010 |
Why?
|
Integrin alphaV | 1 | 1999 | 55 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3306 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5872 | 0.010 |
Why?
|
Pregnancy | 2 | 2011 | 29087 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2010 | 5095 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1083 | 0.010 |
Why?
|
Mitogens | 1 | 1997 | 232 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7873 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8425 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1420 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16665 | 0.010 |
Why?
|
Interleukin-10 | 1 | 1998 | 1200 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1831 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14720 | 0.010 |
Why?
|
Antigens | 1 | 1998 | 1462 | 0.010 |
Why?
|
Infant | 1 | 2014 | 35070 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18006 | 0.010 |
Why?
|
Spleen | 1 | 1997 | 2359 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1998 | 2006 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16331 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6382 | 0.000 |
Why?
|
Aged | 2 | 2013 | 162944 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7721 | 0.000 |
Why?
|
Middle Aged | 2 | 2013 | 213127 | 0.000 |
Why?
|
HIV Infections | 1 | 2010 | 16678 | 0.000 |
Why?
|